New drug delivery system may offer clinical advantages in prostate cancer treatment.
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D016503:Drug Delivery Systems; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage*; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D018931:Antineoplastic Agents, Hormonal; D016729:Leuprolide